RaySearch Laboratories (STO:RAYB):
JANUARY 1 - SEPTEMBER 30, 2011
· Net sales for the period totaled SEK 80.3 M (83.0)
· Profit after tax amounted to SEK 10.2 M (17.5) and earnings per share totaled SEK 0.30 M (0.51)
· Operating profit totaled SEK 13.0 M (24.5)
· Cash flow was a negative SEK 30.8 M (neg: 2.8)
· A total of seven orders for RayStation® were received from Switzerland, Canada, the Netherlands and the US
· A sales organization was established in the US in January
· RaySearch licensed pioneering technology from Princess Margaret Hospital in March
· RaySearch became involved in a US patent dispute in May
· Distribution agreements were signed for the Italian market in September
· The first patient was treated with RayStation® in September
AFTER THE END OF THE PERIOD
· Two US hospitals placed orders for RayStation® in October
· RaySearch entered South Korean distribution agreement in November
"Financially, we had a strong third quarter so we recovered after a weak first half of the year. The end of the year promises to be highly interesting," says Johan Löf, President of RaySearch.
"In 2011, we have focused on our strategic shift from complete dependence on partners to establishing opportunities to sell directly to clinics in parallel with our partner-based business model. Our order book has now started to grow as a result of the considerable interest shown in RayStation®, particularly in the US, and we have high hopes of completing a few more transactions toward the end of 2011," concludes Johan Löf.